Correction to Abbott Labs Enters Into Consent Decree with FDA Article
16 Maio 2022 - 7:00PM
Dow Jones News
Chief Executive Robert Ford said the company's "No. 1 priority
is getting infants and families the high-quality formulas they
need." Abbott Labs Enters Into Consent Decree With FDA at 4:40 p.m.
ET incorrectly said the priority was No. 2.
(END) Dow Jones Newswires
May 16, 2022 17:45 ET (21:45 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
